XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Net Cash Provided by (Used in) Operating Activities [Abstract]      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (310,617) $ 18,264 $ 117,333
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]      
Depreciation, Depletion and Amortization, Nonproduction 97,955 101,272 111,791
Amortization of contract acquisition costs 1,995 2,288 2,065
Amortization of Debt Issuance Costs 2,020 1,067 1,018
Imputed interest expense and fair value adjustments to contingent consideration (1,496) 7,579 1,746
Accounts Receivable, Credit Loss Expense (Reversal) 3,596 2,009 9,391
(Gain) loss on disposal of assets (13,281) 2,219 1,916
Asset Impairment Charges 244,093 11,733 13,749
Loss on dissolution of subsidiary 0 301 0
Deferred Income Tax Expense (Benefit) 58,530 (7,528) (11,001)
Excess tax benefit from equity-based awards 4,352 1,705 (1,122)
Share-Based Payment Arrangement, Noncash Expense 18,690 22,071 17,571
(Gain) loss on foreign currency derivatives 384 (3) (7)
Increase (Decrease) in Operating Capital [Abstract]      
Accounts receivable (66,329) 22,359 (74,564)
Prepaids and other assets (17,120) 8,570 43,699
Increase (Decrease) in Accounts Payable and Accrued Liabilities (43,220) 9,518 (12,695)
Deferred revenue and other liabilities (38,370) (58,659) (83,842)
Net cash (used in) provided by operating activities (58,818) 144,765 137,048
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Proceeds from Sale of Productive Assets 45,650 261 229
Purchases of property, plant and equipment (45,173) (67,839) (84,012)
Acquisitions, net of cash acquired for current period and prior period, respectively 0 0 (142,420)
Net cash used in investing activities 477 (67,578) (226,203)
Net Cash Provided by (Used in) Financing Activities [Abstract]      
Proceeds from (Repayments of) Lines of Credit (20,000) 35,000 169,000
Payments on other debt (2,405) (2,317) (3,245)
Payments of contingent consideration and hold back payments to acquisitions 0 (37,676) (9,600)
Dividends paid to shareholders (2,847) (49,232) (48,072)
Payments of debt issuance costs (2,804) 0 0
Payments to noncontrolling interest (9,226) (10,972) (11,883)
Tax payments related to issuance of restricted stock units (1,014) (3,037) (7,164)
Net cash (used in) provided by financing activities (38,296) (68,234) 89,036
Effect of exchange rate changes on cash, cash equivalents and restricted cash 7,723 (2,112) (13,499)
Increase (decrease) in cash, cash equivalents and restricted cash (88,914) 6,841 (13,618)
Cash, cash equivalents and restricted cash, beginning of period 173,905 167,064 180,682
Cash, cash equivalents and restricted cash, end of period 84,991 173,905 167,064
Supplemental Cash Flow Information [Abstract]      
Interest Paid, Excluding Capitalized Interest, Operating Activities 82,076 77,199 34,984
Income Taxes Paid 43,611 46,129 42,563
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]      
Acquisition of long lived assets through finance leases 886 3,126 461
Acquisition of equipment through increase in accounts payable, net $ (2,872) $ 2,626 $ 3,346